Mar 31, 2017

ANI Pharmaceuticals Q1 2017 Earnings Report

Total Revenue
$36.6M
Previous year: $20.6M
+78.2%
EPS
$0.74
Previous year: $0.76
-2.6%
Gross Profit
$20.2M
Previous year: $17.1M
+18.1%
Cash and Equivalents
$10.8M
Previous year: $77.7M
-86.1%
Free Cash Flow
$4.39M
Previous year: $9.6M
-54.3%
Total Assets
$357M
Previous year: $292M
+22.5%

ANI Pharmaceuticals

ANI Pharmaceuticals